Embecta Corp. (EMBC)
NMS · Healthcare · Medical Instruments & Supplies
$3.10
+0.65%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$183.9M
Shares Outstanding
59.3M
P/S (TTM)
0.2x
P/E (TTM)
1.6x
Exchange
NMS
Currency
USD
About Embecta Corp.
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 295.5M | 264.0M | 261.2M | 221.8M |
| Gross Profit | 197.1M | 158.5M | 161.7M | 127.8M |
| Operating Income | 105.0M | 64.3M | 76.3M | 42.9M |
| Net Income | 45.5M | 26.4M | 44.1M | -4.1M |
| Diluted EPS | $0.78 | $0.45 | $0.74 | $-0.07 |
Annual Financials
| Metric | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | 1.1B | 1.1B | 1.1B | 1.1B |
| Gross Profit | 774.9M | 749.9M | 735.2M | 676.8M |
| Operating Income | 368.5M | 224.0M | 285.0M | 296.4M |
| Net Income | 223.6M | 70.4M | 78.3M | 95.4M |
| Diluted EPS | $3.89 | $1.22 | $1.34 | $1.62 |